undefined
EUTM file information

018858616

PEDMARQSI

April 4, 2023

Trademark Summary

The trademark application PEDMARQSI was filed by Fennec Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 18, 2023, and it was registered by office on August 25, 2023 without any oppositions.

The application was filed in English (German was selected as the second language).

Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations, namely, sodium thiosulfate used for the prevention of ototoxicity from cisplatin in paediatric patients.